Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Post by TheEgyptianon May 08, 2019 11:47pm
262 Views
Post# 29727290

Beacon Securities forecast

Beacon Securities forecastCooper thinks Viemed will post EBITDA of (All figures USD) $22.8-million on revenue of $83.9-million in fiscal 2019. He expects those numbers will improve to EBITDA of $29.7-million on a topline of $109.1-million the following year.

I believe Mr Cooper is very low on 2019 revenue. Assume a growth of 8 to 10%/quarter
Q1 rev   Q2.        Q3.      Q4.       Total
$20.5.    $22.5.    $24.    $26.      $93 USD

Let's not convert to CDN since it is a weak currency and the company on due time will trade mostly on USA exchange. Assume 30% growth in 2020, revenue can be $122M USD. All organic growth.
Bullboard Posts